{"url":"https://lda.senate.gov/api/v1/filings/12fb8b38-059e-4202-8ff8-29adec07d910/","filing_uuid":"12fb8b38-059e-4202-8ff8-29adec07d910","filing_type":"2T","filing_type_display":"2nd Quarter - Termination","filing_year":2023,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/12fb8b38-059e-4202-8ff8-29adec07d910/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer Holmes","dt_posted":"2023-07-20T18:49:19-04:00","termination_date":"2023-05-24","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"418 C St NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":400774330,"url":"https://lda.senate.gov/api/v1/registrants/400774330/","house_registrant_id":null,"name":"S-3 GROUP","description":"Government consulting firm","address_1":"418 C St NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER HOLMES","contact_telephone":"+1 202-819-5036","dt_updated":"2026-07-25T19:32:13.062375-04:00"},"client":{"id":54952,"url":"https://lda.senate.gov/api/v1/clients/54952/","client_id":54952,"name":"GENEVANT SCIENCES, INC.","general_description":"Provide services to technology-focused nucleic acid development and delivery companies","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-02-25"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Healthcare matters","foreign_entity_issues":"Genevant Sciences Holdings Limited, London, GBR Genevant Sciences Ltd., Hamilton, BER Roivant Sciences, Ltd., Hamilton, BER","lobbyists":[{"lobbyist":{"id":69835,"prefix":null,"prefix_display":null,"first_name":"MICHAELEEN","nickname":null,"middle_name":"EARLE","last_name":"CROWELL","suffix":null,"suffix_display":null},"covered_position":"Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders","new":false},{"lobbyist":{"id":139496,"prefix":"mr","prefix_display":"MR.","first_name":"MARTIN","nickname":null,"middle_name":null,"last_name":"REISER","suffix":null,"suffix_display":null},"covered_position":"Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee","new":false},{"lobbyist":{"id":65617,"prefix":null,"prefix_display":null,"first_name":"KATE","nickname":null,"middle_name":null,"last_name":"DICKENS","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, US Sen Mark Kirk; Leg Director, Rep Mike Castle; Foreign Policy Adv, Rep. Connie Morella","new":false},{"lobbyist":{"id":107322,"prefix":null,"prefix_display":null,"first_name":"OLIVIA","nickname":null,"middle_name":null,"last_name":"KURTZ","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}